SCHEMBL4654049

SCHEMBL4654049

O=C(O)Nc1ccccc1Sc1ccccc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 3/20 0.72
▸ MAPT P10636 2/20 0.72
▸ ALDH1A1 P00352 6/20 0.68
▸ KMT2A Q03164 4/20 0.68
▸ MEN1 O00255 2/20 0.68
▸ BLM P54132 2/20 0.68
▸ L3MBTL1 Q9Y468 8/20 0.67
▸ LMNA P02545 5/20 0.66
▸ HPGD P15428 2/20 0.66
▸ ATM Q13315 1/20 0.66
▸ GLA P06280 1/20 0.62
▸ HTT P42858 3/20 0.57
▸ NPSR1 Q6W5P4 2/20 0.57
▸ CYP1A2 P05177 1/20 0.57
▸ CYP3A4 P08684 1/20 0.57
▸ CYP2D6 P10635 1/20 0.57
▸ CYP2C9 P11712 1/20 0.57
▸ CYP2C19 P33261 1/20 0.57
▸ MAPK1 P28482 1/20 0.57
▸ POLB P06746 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19712968 0.92 TDP1 (0.62) TDP1MAPTALDH1A1KMT2AMEN1
SCHEMBL11349579 0.86 TDP1 (0.55) TDP1MAPTALDH1A1KMT2AMEN1
SCHEMBL28896841 0.84 TDP1 (1.00) TDP1MAPTALDH1A1KMT2AMEN1
SCHEMBL3690292 0.82 TDP1 (0.50) TDP1MAPTALDH1A1KMT2AMEN1
SCHEMBL9049960 0.82 MAPT (0.64) TDP1MAPTALDH1A1KMT2AMEN1
SCHEMBL25386384 0.82 ALDH1A1 (0.68) TDP1MAPTALDH1A1KMT2AMEN1
SCHEMBL11848833 0.81 ALDH1A1 (1.00) TDP1MAPTALDH1A1KMT2AMEN1
SCHEMBL27688958 0.81 TDP1 (0.62) TDP1MAPTALDH1A1KMT2AMEN1
SCHEMBL2935482 0.80 KMT2A (0.68) TDP1MAPTALDH1A1KMT2AMEN1
SCHEMBL7716422 0.80 L3MBTL1 (0.71) TDP1MAPTALDH1A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1660469-B1 PROCESS FOR THE PREPARATION OF 11-(1-PIPERAZINYL)DIBENZO 'B, F! '1 ,4!-THIAZEPINE, AN INTERMEDIATE IN THE SYNTHESIS OF THE ANTIPSYCHOTIC DRUG QUETIAPINE HELM AG (DE) 2007-08-29 — — EP claimed
CN-107001246-B Naphthyl acrylates as writing monomers for photopolymers 科思创德国股份有限公司 2021-02-02 — — CN disclosed
CN-107223121-B Wet stable holographic media 科思创德国股份有限公司 2020-10-27 — — CN disclosed
US-20200283454-A1 INFLUENZA VIRUS REPLICATION INHIBITOR AND USE THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2020-09-10 — — US disclosed
EP-3686201-A1 INFLUENZA VIRUS REPLICATION INHIBITOR AND USE THEREOF Sunshine Lake Pharma Co., Ltd. (CN) 2020-07-29 — — EP disclosed
US-10329244-B2 Moisture-stable holographic media COVESTRO DEUTSCHLAND AG (DE) 2019-06-25 — — US disclosed
US-20170362165-A1 MOISTURE-STABLE HOLOGRAPHIC MEDIA COVESTRO DEUTSCHLAND AG (DE) 2017-12-21 — — US disclosed
WO-2011121602-A1 PROCESS FOR PREPARATION OF DIBENZOTHIAZEPINONE COMPOUNDS HIKAL LIMITED (IN) 2011-10-06 — — WO disclosed
EP-1996568-A2 PROCESS FOR PREPARING DIBENZOTHIAZEPINE COMPOUNDS AstraZeneca UK Limited (GB) 2008-12-03 — — EP disclosed
WO-2007102352-A2 PROCESS FOR PREPARING DIBENZOTHIAZEPINE COMPOUNDS ASTRAZENECA UK LIMITED (GB) 2007-09-13 — — WO disclosed
EP-0008177-B1 VULCANIZABLE RUBBER COMPOSITIONS CONTAINING SUBSTITUTED CARBAMIC ACID ESTERS MONSANTO COMPANY (US) 1981-08-26 — — EP disclosed
EP-0008177-A1 Vulcanizable rubber compositions containing substituted carbamic acid esters MONSANTO COMPANY (US) 1980-02-20 — — EP disclosed
US-4165310-A N-SULFENYL DERIVATIVES OF DI(CARBAMIC ACID ESTERS) USED AS PREMATURE VULCANIZING INHIBITORS MONSANTO COMPANY (US) 1979-08-21 — — US disclosed
US-4156680-A Scorch inhibited vulcanizable rubber compositions containing carbamic acid esters MONSANTO COMPANY (US) 1979-05-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10329244-B2 Moisture-stable holographic media NEFM, MDM4, BHMT2 TDP1 1478/4885MAPT 343/4885ALDH1A1 3155/4885
US-20200283454-A1 INFLUENZA VIRUS REPLICATION INHIBITOR AND USE THEREOF RTF2, POLRMT, RTF1 TDP1 3176/4885MAPT 3630/4885ALDH1A1 2881/4885
US-20170362165-A1 MOISTURE-STABLE HOLOGRAPHIC MEDIA NEFM, MDM4, BHMT2 TDP1 1478/4885MAPT 343/4885ALDH1A1 3155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback